Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers

Active, not recruitingOBSERVATIONAL
Enrollment

1,092

Participants

Timeline

Start Date

April 27, 2020

Primary Completion Date

April 23, 2021

Study Completion Date

May 31, 2025

Conditions
SARS-CoV-2
Interventions
DIAGNOSTIC_TEST

Nasal swab

SARS-CoV-2 PCR

DIAGNOSTIC_TEST

Serum testing

Anti-SARS-CoV2 S protein IgG ELISA, serological changes after SARS-CoV-2 vaccination

Trial Locations (1)

Unknown

Greifswald University Medicine, Greifswald

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Friedrich Loefler Institute for Animal Health

UNKNOWN

collaborator

EUROIMMUN AG

UNKNOWN

lead

University Medicine Greifswald

OTHER